Description
Extensive efforts have been made to develop efficient and low-cost methods for diagnostics to identify molecular biomarkers that are linked to a wide array of conditions, including cancer. A highly developed method includes utilizing the gene-editing enzyme CRISPR-Cas12a (Cpf1), which demonstrates double-stranded DNase activity with RuvC catalytic domain with high sensitivity and specificity.
Copyright Statement
Download count: 0
Details
Contributors
- Staren, Michael Steven (Author)
- Green, Alexander (Thesis director)
- Stephanopoulos, Nicholas (Committee member)
- Diehnelt, Chris (Committee member)
- School of Life Sciences (Contributor)
- College of Health Solutions (Contributor)
- Barrett, The Honors College (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2019-05
Resource Type
Collections this item is in